Evaluation of serum concentration of complement component C4 and IgA, IgG, IgM immunoglobulins in patients with essential hypertension;Ocena stȩżenia składowej dopełniacza C4 oraz immunoglobulin IgA, IgG, IgM w surowicy krwi u chorych na pierwotne nadciśnienie tȩtnicze

Polskie Archiwum Medycyny Wewnetrznej

Volumn 103, Issue 5-6, 2000, Pages 247-251

  Tomaszewski, Maciej ^a,b   Zukowska Szczechowska, Ewa ^a   Grzeszczak, Władysław ^a  

^a Kat i Klinika Chorob W   (Poland)

^b Kat i Klinika Chorob W   (Poland)

Author keywords

Complement system; Essential hypertension; Immunoglobulins; Immunological system

Indexed keywords

COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; AGED; COMPLEMENT C4; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED;

EID: 0034189828     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Frostegard J., Wu R., Gillis-Haegerstrand C., Lemne C., de Faire U.: Antibodies to endothelial cells in borderline hypertension. Circulation, 1998, 98, 1092.
2. The sixth report of the Joint Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med., 1997, 157, 2413.
3. Frostegard J., Lemne C., Andersson B., van der Zee R., Kiessling R., de Faire U.: Association of serum antibodies to heat-shock protein 65 with borderline hypertension. Hypertension, 1997, 29, 40.
4. Chen C., Schachter D.: Elevation of plasma immunoglobulin A in the spontaneously hypertensive rat. Hypertension, 1993, 21, 731.
5. Leftos N., Boura P., Boudonas G. i wsp.: Immunopathogenic mechanisms in hypertension. Am. J. Hypertens., 1995, 8, 1141.
6. Boudonas G., Boura P., Lefkos N., Zacharioydaki E., Efthimiadis A.: A possible role for autoantibodies in left ventricular hypertrophy. Cardiology, 1994, 84, 278.
7. Yasuda M., Takeuchi K., Hiruma M. i wsp.: The complement system in ischemic heart disease. Circulation, 1990, 81, 156.
8. Roitt I., Brostoff J., Male D.: Immunologia. Wydawnictwo Medyczne Słotwiński Verlag, Brema, 1996.
9. Bredt W., Wellek B., Brunner H., Loos M.: Interactions between Mycoplasma pneumoniae and the first components of complement. Infect. Immun., 1977, 15, 7.
10. Takeichi N., Hamada J., Takimoto M., Fujiwara K., Kobayashi H.: Depression of T-cell mediated immunity and enhancement of autoantibody production by natural infection with microorganisms in spontaneously hypertensive rats (SHR). Microbiol. Immunol., 1988, 32, 1235.
11. Cook P.J., Lip G.Y.H., Davies P., Beevers D.g., Wise R., Honeybourne D. : Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension, 1998, 31, 589.
12. Fagerberg B., Gnarpe J., Gnarpe H., Agewall S., Wikstrand J.: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke, 1999, 30, 299.
13. Andersen U.O.: Immunologic reactions in essential hypertension. Ugeskr. Laeger, 1990, 152, 653.